Last Round
Series A
Jun 25, 2024
Total Funding Raised
$82M
Company Overview
Avdarna Therapeutics is a biotechnology company that develops AI-generated proprietary protein and peptide therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
biotechnologydrug discoveryAI drug discoveryprotein therapeuticspeptide therapeuticsbiologicsantibody-drug conjugatesADCnanobodiesoncology therapeuticsprecision medicinein silico drug designGLP-1 agoniststherapeutic pipelinebiotech partnering
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avdarna Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Avdarna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2024 |
Avdarna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Insight | Series A |
| Innovation Endeavors | Series A |
| OrbiMed | Series A |
| Arc Ventures | Series A |
| Delos Capital Partners | Series A |
| Invus | Series A |
| J.P. Morgan Life Sciences Private Capital | Series A |
Avdarna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avdarna Therapeutics's valuation, stock price, and market status.